Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients

Overview of attention for article published in Frontiers in immunology, December 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,069 followers.

RT @methylomic: Rheumatoid arthritis (RA) patients are currently treated with biological agents mostly aimed at cytokine blockade, such as…

15 Apr 2024

Reply Repost Favourite

Rheumatoid arthritis (RA) patients are currently treated with biological agents mostly aimed at cytokine blockade, such as tumor necrosis factor-alpha (TNFα). Currently, there are no biomarkers to predict therapy response. Read more: https://t.co/zQXK7N2W

12 Apr 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients: Backgr…

23 Dec 2023

Reply Repost Favourite

New Research: Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients: Background and aims Rheumatoid arthritis (RA) patients are currently treated with biological agents mostly aimed at cytokine… https://t.co/f

23 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.